Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir

Journal of Pharmaceutical Sciences

Volumn 90, Issue 3, 2001, Pages 288-297

  Mann, Angelika ^a,b   Kiefer, Markus ^b   Leuenberger, Hans ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Acyclovir; Eye; Nanospheres; Toxicity and bioavailability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACICLOVIR; MACROGOL; NANOPARTICLE; POLY(ETHYL 2 CYANOACRYLATE);

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG TOLERABILITY; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PARTICLE SIZE; POLYMERIZATION; RABBIT; ZETA POTENTIAL;

EID: 0035090503     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5     Document Type: Article

References (41)

1. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
2. Pharmacokinetics and tolerance of acyclovir, a new antiherpesvirus agent, in humans
3. Acyclovir inhibits hepatitis B virus replication in man
4. Antiviral agents
5. Chemotherapy of ocular viral infections and tumors
6. Herpetic infections
7. Characterization and in vivo ocular absorption of liposome-encapsulated acyclovir
8. Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts
9. Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: Characterization of the colloidal drug carrier formulation
10. Polyalkylcyanoacrylate nanoparticles as drug carrier: Present state and perspectives
11. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles
12. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles
13. Design of new formulation for topical ocular administration: Polymeric nanocapsules containing metipranolol
14. Factors influencing the body distribution of polyacrylic nanoparticles
15. 14C-poly(methylmethacrylate) nanoparticles to their body distribution
16. Surface modification of poly-(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)poly(ethylene glycol) copolymers
17. Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system
18. Development of sterically stabilized poly(isobutyl-2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol)
19. The dissolution of nortriptyline. HCl from polyethylene glycol solid dispersions
20. Evaluation of polyalkylcyanoacrylate nanoparticles as potential drug carrier: Preparation, morphological characterization and loading capacity
21. Eye irritation
22. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs
23. Poly(alkylcyanoacrylate) nanocapsules: Physicochemical characterization and mechanism of formation
24. Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
25. Vidarabine-loaded nanoparticles: A physicochemical study
26. Polyacrylic acid/polyvinylpyrrolidone biopolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome
27. Steric stabilization of nanoparticles: Size and surface properties
28. Nanoparticles in drug delivery
29. Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles
30. An interpretative analysis of the effects of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process
31. Poly(ε-caprolactone) nanocapsules in carteolol ophthalmic delivery
32. Advanced corneal delivery systems: Liposomes
33. Bioadhesives for optimization of drug delivery
34. Hydrogels as mucoadhesive and bioadhesive materials: A review
35. Topical drug delivery: Recent developments and challenges
36. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model
37. 14c)-acrylate nanoparticle in the albino rabbit
38. Studies on the transport pathway of PBCA nanoparticles in ocular tissues
39. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2)